长链非编码RNA通过ceRNA调控血管平滑肌细胞增殖的研究进展
Advances in the Regulation of Vascular Smooth Muscle Cell Proliferation by Long Non-Coding RNA through ceRNA
DOI: 10.12677/ACM.2022.1291205, PDF,   
作者: 张 华：济宁医学院临床医学院，山东 济宁；济宁医学院附属医院心血管内科，山东 济宁；陈雪英, 刘立新*：济宁医学院附属医院心血管内科，山东 济宁
关键词: 长链非编码RNA；血管平滑肌细胞；细胞增殖；动脉粥样硬化；内源性竞争RNA；Long Non-Coding RNA； Vascular Smooth Muscle Cells； Cell Proliferation； Atherosclerosis； Competitive Endogenous RNA
摘要: 长链非编码RNA (LncRNAs)是一类长度超过200个核苷酸的RNA分子，特点是不编码蛋白质，在动脉粥样硬化疾病发生发展中发挥重要作用。血管平滑肌异常增殖会导致血管病理性重塑，LncRNAs可通过多种机制调控血管平滑肌增殖。本文主要对LncRNAs通过ceRNA调控血管平滑肌细胞增殖的研究进展做一综述。
Abstract: Long non-coding RNAs (LncRNAs) are a class of RNA molecules more than 200 nucleotides in length, characteristically do not encode proteins, and play an important role in the development of athero-sclerotic disease. Abnormal proliferation of vascular smooth muscle leads to pathological vascular remodeling, and LncRNAs can regulate vascular smooth muscle proliferation through multiple mechanisms. In this paper, we review the progress of LncRNAs regulating vascular smooth muscle cell proliferation through ceRNAs.
文章引用：张华, 陈雪英, 刘立新. 长链非编码RNA通过ceRNA调控血管平滑肌细胞增殖的研究进展[J]. 临床医学进展, 2022, 12(9): 8359-8364. https://doi.org/10.12677/ACM.2022.1291205

参考文献

[1] Cao, Q., Wu, J., Wang, X., et al. (2020) Noncoding RNAs in Vascular Aging. Oxidative Medicine and Cellular Longev-ity, 2020, Article ID: 7914957. [Google Scholar] [CrossRef] [PubMed]
[2] Fasolo, F., Di Gregoli, K., Maegdefessel, L., et al. (2019) Non-Coding RNAs in Cardiovascular Cell Biology and Atherosclerosis. Cardiovascular Research, 115, 1732-1756. [Google Scholar] [CrossRef] [PubMed]
[3] Simion, V., Haemmig, S. and Feinberg, M.W. (2019) LncRNAs in Vascular Biology and Disease. Vascular Pharmacology, 114, 145-156. [Google Scholar] [CrossRef] [PubMed]
[4] Zhou, H., Wang, B., Yang, Y.X., et al. (2019) Long Noncoding RNAs in Pathological Cardiac Remodeling: A Review of the Update Literature. BioMed Research International, 2019, Article ID: 7159592. [Google Scholar] [CrossRef] [PubMed]
[5] Indolfi, C., Iaconetti, C., Gareri, C., et al. (2019) Non-Coding RNAs in Vascular Remodeling and Restenosis. Vascular Pharmacology, 114, 49-63. [Google Scholar] [CrossRef] [PubMed]
[6] Wang, L., Cho, K.B., Li, Y., et al. (2019) Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Tar-gets for Colorectal Cancer. International Journal of Molecular Sciences, 20, Article No. 5758. [Google Scholar] [CrossRef] [PubMed]
[7] Grootaert, M. and Bennett, M.R. (2021) Vascular Smooth Muscle Cells in Atherosclerosis: Time for a Re-Assessment. Cardiovascular Research, 117, 2326-2339. [Google Scholar] [CrossRef] [PubMed]
[8] Harman, J.L. and Jorgensen, H.F. (2019) The Role of Smooth Muscle Cells in Plaque Stability: Therapeutic Targeting Potential. British Journal of Pharmacology, 176, 3741-3753. [Google Scholar] [CrossRef] [PubMed]
[9] Ding, Y., Tang, T., Lu, J. and Wang, J. (2021) Circ_UBR4 Knockdown Alleviates Oxidized Low-Density Lipoprotein-Provoked Growth and Migration of Human Vascular Smooth Muscle Cells by Acting on the miR-637/FOXO4 Pathway. Journal of Cardiovascular Pharmacology, 78, 534-543. [Google Scholar] [CrossRef] 
[10] Lim, S. and Park, S. (2014) Role of Vascular Smooth Mus-cle Cell in the Inflammation of Atherosclerosis. BMB Reports, 47, 1-7. [Google Scholar] [CrossRef] 
[11] Kobiyama, K. and Ley, K. (2018) Atherosclerosis. Circula-tion Research, 123, 1118-1120. [Google Scholar] [CrossRef] 
[12] Shi, X., Wei, Y.T., Li, H., et al. (2020) Long Non-Coding RNA H19 in Atherosclerosis: What Role? Molecular Medicine, 26, Article No. 72. [Google Scholar] [CrossRef] [PubMed]
[13] Ghafouri-Fard, S., Gholipour, M. and Taheri, M. (2021) The Emerging Role of Long Non-Coding RNAs and Circular RNAs in Coronary Artery Disease. Frontiers in Cardiovascu-lar Medicine, 8, Article ID: 632393. [Google Scholar] [CrossRef] [PubMed]
[14] Dong, H., Jiang, G., Zhang, J., et al. (2022) LncRNA OIP5-AS1 Promotes the Proliferation and Migration of Vascular Smooth Muscle Cells via Regulating miR-141-3p/HMGB1 Path-way. The American Journal of the Medical Sciences, 363, 538-547. [Google Scholar] [CrossRef] [PubMed]
[15] Liu, W., Che, J., Gu, Y., et al. (2021) Silencing of LncRNA SNHG12 Inhibits Proliferation and Migration of Vascular Smooth Muscle Cells via Targeting miR-766-5p/EIF5A Axis. Advances in Clinical and Experimental Medicine, 30, 591-598.
[16] Guo, C., Qi, Y., Qu, J., et al. (2020) Pathophysio-logical Functions of the lncRNA TUG1. Current Pharmaceutical Design, 26, 688-700. [Google Scholar] [CrossRef] [PubMed]
[17] Pardini, B. and Dragomir, M.P. (2021) SCIRT lncRNA Blocks the Shot of Breast Cancer Cells Self-Renewal Mechanism. Cancer Research, 81, 535-536. [Google Scholar] [CrossRef] 
[18] Bai, Y., Zhang, Q., Su, Y., et al. (2019) Modulation of the Proliferation/Apoptosis Balance of Vascular Smooth Muscle Cells in Atherosclerosis by lncRNA-MEG3 via Regulation of miR-26a/Smad1 Axis. International Heart Journal, 6, 444-450. [Google Scholar] [CrossRef] [PubMed]
[19] Zhang, B., Dong, Y. and Zhao, Z. (2019) LncRNA MEG8 Regulates Vascular Smooth Muscle Cell Proliferation, Migration and Apoptosis by Targeting PPARα. Biochemical and Biophysical Research Communications, 510, 171-176. [Google Scholar] [CrossRef] [PubMed]
[20] Wu, L., Li, Y., Zhang, D., et al. (2019) LncRNA NEXN-AS1 At-tenuates Proliferation and Migration of Vascular Smooth Muscle Cells through Sponging miR-33a/b. RSC Advances, 9, 27856-27864. [Google Scholar] [CrossRef] 
[21] Wang, Y., Sun, X. and Sun, X. (2022) The Functions of Long Non-Coding RNA (lncRNA) H19 in the Heart. Heart, Lung and Circulation, 31, 341-349. [Google Scholar] [CrossRef] [PubMed]
[22] Horita, H., Wysoczynski, C.L., Walker, L.A., Moulton, K.S., et al. (2016) Nuclear PTEN Functions as an Essential Regulator of SRF-Dependent Transcription to Control Smooth Muscle Differentiation. Nature Communications, 7, Article No. 10830. [Google Scholar] [CrossRef] [PubMed]
[23] Zhang, L., Zhou, C., Qin, Q., et al. (2019) LncRNA LEF1-AS1 Regulates the Migration and Proliferation of Vascular Smooth Muscle Cells by Targeting miR-544a/PTEN Axis. Journal of Cellular Biochemistry, 120, 14670-14678.[CrossRef] [PubMed]
[24] Pellegrini, L., Foglio, E., Pontemezzo, E., et al. (2019) HMGB1 and Repair: Focus on the Heart. Pharmacology & Therapeutics, 196, 160-182. [Google Scholar] [CrossRef] [PubMed]
[25] Mathews, M.B. and Hershey, J.W. (2015) The Translation Factor eIF5A and Human Cancer. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1849, 836-844. [Google Scholar] [CrossRef] [PubMed]
[26] Liu, Q., Liu, H., Cheng, H., et al. (2017) Downregulation of long Noncoding RNA TUG1 Inhibits Proliferation and Induces Apoptosis through the TUG1/miR-142/ZEB2 Axis in Bladder Cancer Cells. OncoTargets and Therapy, 10, 2461-2471. [Google Scholar] [CrossRef] 
[27] Li, F.P., Lin, D.Q. and Gao, L.Y. (2018) LncRNA TUG1 Promotes Proliferation of Vascular Smooth Muscle Cell and Ath-erosclerosis through Regulating miRNA-21/PTEN Axis. European Review for Medical and Pharmacological Sciences, 22, 7439-7447. [Google Scholar] [CrossRef] [PubMed]
[28] Lokman, N.A., Ween, M.P., Oehler, M.K., et al. (2011) The Role of Annexin A2 in Tumorigenesis and Cancer Progression. Cancer Microenvironment, 4, 199-208. [Google Scholar] [CrossRef] 

为你推荐